Maze Therapeutics, Inc. Common Stock (MAZE) — Capital Reinvestment Ratio
Maze Therapeutics, Inc. Common Stock (MAZE) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($145.05 Million) in capital expenditures ($160.00K). See Maze Therapeutics, Inc. Common Stock (MAZE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Maze Therapeutics, Inc. Common Stock Capital Reinvestment Ratio (2024–2024)
This chart tracks Maze Therapeutics, Inc. Common Stock's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year Capital Reinvestment Ratio for Maze Therapeutics, Inc. Common Stock from 2024 to 2024. For live market cap and broader valuation context, see Maze Therapeutics, Inc. Common Stock (MAZE) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | $75.95 Million | $1.15 Million | — |